Premium
Toxic epidermal necrolysis and co‐existent SARS‐CoV‐2 (COVID‐19) treated with intravenous immunoglobulin: ‘ Killing 2 birds with one stone ’
Author(s) -
Saha M.,
D’Cruz A.,
Paul N.,
Healy R.,
Collins D.,
Charles D.A.,
Sahu S.,
Fonia A.
Publication year - 2021
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16887
Subject(s) - medicine , toxic epidermal necrolysis , covid-19 , intravenous immunoglobulin therapy , antibody , virology , immunoglobulin g , betacoronavirus , dermatology , immunology , outbreak , disease , infectious disease (medical specialty)